SCHEMBL21351498

SCHEMBL21351498

c1ccc(-c2ncc3c4ccccc4c4cnc(-c5ccc6c(n5)-c5ccccc5-c5ccccc5-c5ccccc5-6)nc4c3n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ NFKB1 P19838 2/20 0.34
▸ NFKB2 Q00653 2/20 0.34
▸ RELA Q04206 2/20 0.34
▸ MTOR P42345 1/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ HPGDS O60760 1/20 0.33
▸ ATR Q13535 1/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21351501 0.80 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9AMAPTLMNA
SCHEMBL21351416 0.75 NPC1 (0.53) SMN1; SMN2NPC1RAB9AMAPTLMNA
SCHEMBL21351427 0.73 NPC1 (0.54) SMN1; SMN2NPC1RAB9AMAPTLMNA
SCHEMBL14380306 0.72 SMN1; SMN2 (0.48) SMN1; SMN2NPC1RAB9AMAPTLMNA
SCHEMBL30332771 0.72 MAPT (0.42) SMN1; SMN2NPC1RAB9AMAPTLMNA
SCHEMBL21351106 0.72 NPC1 (0.50) SMN1; SMN2NPC1RAB9AMAPTLMNA
SCHEMBL21351365 0.71 RAB9A (0.43) SMN1; SMN2NPC1RAB9AMAPTLMNA
SCHEMBL21351417 0.70 MEN1 (0.44) SMN1; SMN2NPC1RAB9AMAPTLMNA
SCHEMBL21351405 0.70 NPC1 (0.51) SMN1; SMN2NPC1RAB9AMAPTLMNA
SCHEMBL21351450 0.70 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190280214-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-09-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190280214-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LEF1, OCIAD1, OCIAD2 SMN1; SMN2 3926/4885NPC1 1575/4885RAB9A 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback